LIRVX | OAZIX | LIRVX / OAZIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 4 years | - |
Gain YTD | 13.581 | -0.859 | -1,581% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 423M | 18.1B | 2% |
Annual Yield % from dividends | 3.21 | 2.16 | 148% |
Returns for 1 year | 17.85 | 4.27 | 418% |
Returns for 3 years | 11.23 | -3.25 | -345% |
Returns for 5 years | 34.06 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYMGX | 55.45 | 0.89 | +1.63% |
Rydex S&P MidCap 400 Pure Growth A | |||
CLVRX | 33.50 | 0.33 | +0.99% |
Calvert US Large Cap Value Rspnb Idx R6 | |||
MFVSX | 19.63 | 0.14 | +0.72% |
MassMutual Equity Opports R5 | |||
SHSAX | 72.95 | 0.30 | +0.41% |
BlackRock Health Sciences Opps Inv A | |||
JSPIX | 24.08 | 0.09 | +0.38% |
Jackson Square Large-Cap Growth Instl |